Morepen Laboratories share news, announcements and annual reports
NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap
Morepen Laboratories Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1993 on BSE, Nov 1999 on NSE
Last close ₹107.69down ₹5.66 (4.99%)BSE ₹108.05
Share price at the NSE close on 2 Nov 2026. Previous close ₹113.35.
2 Nov: open ₹107.69, high ₹107.69, low ₹107.69
52-week range of traded prices to 2 Nov 2026
₹33.05Low, 30 Mar 2026₹150.70High, 7 Oct 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,901 Cr1,108th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.30
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.19%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.22
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 8,39,229
Morepen Laboratories share news and announcements
608 announcements, routine notices left out, newest first. Page 10 of 13.
Sep 2016
23 Sep · Regulation 44(3) of SEBI (LODR), Reg., 2015
23 Sep · News Verification
Exchange has sought clarification from Morepen Laboratories Limited with respect to recent news item captioned "Morepen in talks to sell OTC business to Piramals." In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Aug 2016
Jul 2016
29 Jul · Board meeting
Inter-alia, to consider, approve and take on record the Un-Audited Financial Results of the Company for the Quarter ended June 30, 2016.
May 2016
Apr 2016
Feb 2016
Jan 2016
Nov 2015
Oct 2015
Sep 2015
18 Sep · Disclosure of Voting Pattern - Clause 35A
Aug 2015
Jul 2015
May 2015
4 May · Board meeting
Inter-alia, to consider, approve and take on record the Audited Financial Results of the Company for the Quarter and Year ended March 31, 2015.
Apr 2015
Feb 2015
Jan 2015
30 Jan · Board meeting
Inter-alia, to consider, approve and take on record the Un-audited Financial Results of the Company for the Quarter and Nine months ended 31st December, 2014.
Nov 2014
Oct 2014
Sep 2014
3 Sep · Meeting
Company has fixed Book Closure from September 15, 2014 to September 19, 2014 (both days inclusive) for the purpose of Annual General Meeting scheduled to be held on September 19, 2014.
Aug 2014
27 Aug · Meeting
Annual General Meeting of the Company is scheduled to be held on September 19, 2014.
Jul 2014
30 Jul · Corporate action
Company has fixed Record Date as August 11, 2014 for the purpose of determining the number of shareholders entitled to vote at the e-voting facility being provided in the ensuing Annual General Meeting of the Company
May 2014
Feb 2014
12 Feb · Results
Nov 2013
13 Nov · Results